Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Gastric microbiome signature to predict metachronous recurrence after endoscopic resection of gastric neoplasms.
Authors
Hokyoung Lee
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
Hokyoung Lee , Cheol Min Shin , Young Hoon Chang , Hyuk Yoon , Young Soo Park , Nayoung Kim , Dong Ho Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
NCT04830618
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 399)
DOI
10.1200/JCO.2024.42.3_suppl.399
Abstract #
399
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Long-term outcome of endoscopic submucosal dissection for early gastric cancer compared to surgical resection.
First Author: Eun Hui Sim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Protocol for open-label, randomised, controlled trial of intensive surveillance vs. standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer (SARONG trial).
First Author: Sheraz Markar
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Multifocal early gastric neoplasms of three or more lesions versus single lesion without recurrence: A comparative study.
First Author: Gyu Young Pih
Poster
2021 ASCO Annual Meeting
Risk factors for recurrence in each pattern after curative gastrectomy for pStage II/III gastric cancer: An exploratory analysis of a randomized controlled trial (JCOG1001).
First Author: Tetsuro Toriumi